Abstract: This paper presents a novel actuator system combining a twisted string actuator (TSA) with a winch mechanism. Relative to traditional hydraulic and pneumatic systems in robotics, TSAs are ...

It almost goes without saying, but in the pass-happy NFL, no team can have too many capable cornerbacks. Such was certainly the case with the Buffalo Bills last season. With first-round rookie ...

Solutions provide end-to-end electrical and optical validation from R&D through high-volume manufacturing Keysight Technologies, Inc. (NYSE: KEYS) today introduced new 224G test solutions that expand ...

Abstract: This paper presents a novel single-motor actuator that integrates a twisted string actuator (TSA) and a winch mechanism with passive automatic clutches. This approach enables seamless ...

The Seattle Seahawks are getting ready for free agency and that means bringing back some of their exclusive rights free agents. The team announced that it had tendered running back George Holani, ...

Enterprise Strategy Group (ESG), now part of Omdia, released a technical validation report confirming that the Huawei DCS Full-Stack Data Center Solution (Huawei DCS solution) fulfills the data center ...

As billions of dollars pour into blockchain infrastructure in 2026, a fundamental debate is fracturing the development community. While Layer 2 scaling solutions dominate recent market narratives, a ...

New validation solutions enable data center operators to overcome bandwidth, latency, and interoperability challenges as AI infrastructure scales Keysight receiver conformance test software for UALink ...

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.

Rapid AI adoption is driving unprecedented demand for high-density compute, real-time data movement, and low-latency memory access. As hyperscalers and enterprises scale-up AI infrastructure, reliable ...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...

Ultra‑Sensitive, Non‑Invasive Surveillance Solution Expected to Launch Commercially in the U.S. in 2027 as Part of CareDx’s Transplant+ Precision Medicine Portfolio CareDx, Inc. (Nasdaq: CDNA) — The ...